Name: MCRB Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: MCRB, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does MCRB have?

Accepted Answer

Seres Therapeutics, Inc. (MCRB) has 12 SEC Form 4 filings (24 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Aug 18, 2026.

Question 2

When was the most recent SEC Form 4 filing for MCRB?

Accepted Answer

The most recent Form 4 filing for MCRB on Tracefour is dated Aug 18, 2026.

Question 3

Who is the most active insider at MCRB?

Accepted Answer

The most active SEC Form 4 filer at MCRB in the rolling window is Director Shaff Eric D., with 3 filings.

Question 4

What is the net insider flow at MCRB over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at MCRB have net sold $6K based on SEC Form 4 disclosures.

Question 5

What is the total insider buy and sell value at MCRB in the current window?

Accepted Answer

Inside the rolling window, insiders at MCRB bought $0 and sold $10K based on SEC Form 4 filings.

						Source
Brady KellyFirst in 3 months	See Remarks	Sale	64	$291	Aug 18	SEC ↗
Shaff Eric D.First in 3 months	Director	Sale	263	$1K	Aug 18	SEC ↗
Henn Matthew RFirst in 3 months	See Remarks	Sale	81	$369	Aug 18	SEC ↗
DesRosier ThomasFirst in 3 months	See Remarks	Sale	82	$373	Aug 18	SEC ↗
Henn Matthew RFirst in 3 months	See Remarks	Sale	77	$580	May 19	SEC ↗
DesRosier ThomasFirst in 3 months	See Remarks	Sale	79	$595	May 19	SEC ↗
Shaff Eric D.First in 3 months	Director	Sale	259	$2K	May 19	SEC ↗
Brady KellyFirst filing	See Remarks	Sale	59	$444	May 19	SEC ↗
Shaff Eric D.First filing	Director	Sale	259	$2K	Feb 18	SEC ↗
Young Teresa L.First filing	See Remarks	Sale	75	$635	Feb 18	SEC ↗
DesRosier ThomasFirst filing	See Remarks	Sale	78	$661	Feb 18	SEC ↗
Henn Matthew RFirst filing	See Remarks	Sale	89	$754	Feb 18	SEC ↗

MCRB

Related companies